Seropositive rheumatoid arthritis
Disease1 paper4 findings
- Humans1
Associations
4Mortality
upin humans1HR 1.93
1 study
Mortality
upin humans1HR 1.93
Seropositive rheumatoid arthritis raises the risk of mortality in humans (adjusted HR 1.93, 95% CI 1.81-2.05).
Humansmatched 1:5 to non-RA controls
Cardiovascular risk and all-cause mortality across low-density lipoprotein cholesterol levels in seropositive rheumatoid arthritis: a nationwide cohort study · Scandinavian journal of rheumatology · 1 Oct 2026
Coronary heart disease
upin humans1HR 1.49
1 study
Coronary heart disease
upin humans1HR 1.49
Seropositive rheumatoid arthritis raises the risk of coronary heart disease in humans (adjusted HR 1.49, 95% CI 1.38-1.62).
Humansmatched 1:5 to non-RA controls
Cardiovascular risk and all-cause mortality across low-density lipoprotein cholesterol levels in seropositive rheumatoid arthritis: a nationwide cohort study · Scandinavian journal of rheumatology · 1 Oct 2026
Stroke
upin humans1HR 1.16
1 study
Stroke
upin humans1HR 1.16
Seropositive rheumatoid arthritis raises the risk of stroke in humans (adjusted HR 1.16, 95% CI 1.08-1.26).
Humansmatched 1:5 to non-RA controls
Cardiovascular risk and all-cause mortality across low-density lipoprotein cholesterol levels in seropositive rheumatoid arthritis: a nationwide cohort study · Scandinavian journal of rheumatology · 1 Oct 2026
Cardiovascular disease
upin humans1HR 1.33
1 study
Cardiovascular disease
upin humans1HR 1.33
Seropositive rheumatoid arthritis raises the risk of cardiovascular disease in humans (adjusted HR 1.33, 95% CI 1.25-1.41).
Humansmatched 1:5 to non-RA controls
Cardiovascular risk and all-cause mortality across low-density lipoprotein cholesterol levels in seropositive rheumatoid arthritis: a nationwide cohort study · Scandinavian journal of rheumatology · 1 Oct 2026